Abstract
Background: Until now, no clinically useful indicators have existed that predict the transition from paroxysmal to persistent atrial fibrillation (AF).
Hypothesis: The current prospective study was conducted for identifying predictors of progression to persistent AF over the long term.
Methods: We studied 102 consecutive patients (mean age: 55 ± 10 years; 75 men and 27 women) diagnosed with paroxysmal AF. Standard 12‐lead electrocardiography, echocardiography, and P‐wave‐triggered signal‐averaged electrocardiography (P‐SAECG) were performed on all patients at the time of their entry into the study.
Results: The mean follow‐up period was 61 ± 13 months. Group 1 (n = 66) comprised patients in whom paroxysmal AF did not progress to persistent AF, and Group 2 (n = 36) comprised those who developed persistent AF. In Group 2 the patients were significantly older, and P‐wave dispersion, filtered P‐wave duration (FPD), and left atrial dimension were significantly higher than in Group 1 (p < 0.05). The root mean square voltage for the last 30 ms of the filtered P‐wave was also significantly lower in Group 2 (p < 0.05). Multivariate logistic regression analysis using these five factors identified left atrial dimension (odds ratio [OR] 2.29; 95% confidence interval [CI] 1.16‐4.54; p = 0.02) and FPD (OR 2.71; 95% CI 1.78‐ 4.13; p< 0.01) as independent predictors of transition to persistent AF. Left atrial dimension ≤ 40 mm predicted progression to persistent AF with a sensitivity of 64%, specificity of 76%, positive predictive value of 59%, negative predictive value of 79%, and an accuracy of 71%. An FPD ≤ 150 ms predicted persistent AF with a sensitivity of 81%, specificity of 91%, positive predictive value of 88%, negative predictive value of 90%, and an accuracy of 87%. Filtered P‐wave duration was a significantly more sensitive and specific predictor than left atrial dimension (p < 0.05).
Conclusion: We conclude that FPD is a clinically useful predictor of progression from paroxysmal to persistent AF over the long term.
Keywords: persistent atrial fibrillation, predictors, filtered P‐wave duration
Full Text
The Full Text of this article is available as a PDF (44.2 KB).
References
- 1. Ostrander LD, Brandt RL, Kjelsberg MO, Epstein FH: Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan. Circulation 1965; 31:888–897 [DOI] [PubMed] [Google Scholar]
- 2. Takahashi N, Seki A, Imataka K, Fujii J: Clinical features of paroxysmal atrial fibrillation: An observation of 94 patients. Jpn Heart J 1981; 22:143–149 [DOI] [PubMed] [Google Scholar]
- 3. Kannel WB, Abbott RD, Savage DD, McNamara PM: Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983; 106:389–396 [DOI] [PubMed] [Google Scholar]
- 4. Komatsu T, Nakamura S, Saitou E, Kobayashi T, Kumagai K, Okumura K: Long‐term efficacy of antiarrhythmic drugs in the prevention of paroxysmal atrial fibrillation; significance of suffering period. Jpn J Electrocardiology 2000; 1:27–32 [Google Scholar]
- 5. Rostagno C, Bacci F, Martelli M, Naldoni A, Bertini G, Gensini G: Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode. Am J Cardiol 1995; 76:837–839 [DOI] [PubMed] [Google Scholar]
- 6. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL: The natural history of lone atrial fibrillation: A population‐based study over three decades. N Engl J Med 1987; 317:669–674 [DOI] [PubMed] [Google Scholar]
- 7. Suttorp MJ, Kingma JH, Koomen EM, van't Hof A, Tijssen JGP, Lie KIL: Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993; 71:710–713 [DOI] [PubMed] [Google Scholar]
- 8. Peterson P, Godtfredsen J: Embolic complications in paroxysmal atrial fibrillation. Stroke 1986; 17:622–626 [DOI] [PubMed] [Google Scholar]
- 9. The stroke prevention in atrial fibrillation investigators : Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992; 116:1–5 [DOI] [PubMed] [Google Scholar]
- 10. Wiener I: Clinical and echocardiographic correlates of systemic embolization in nonrheumatic atrial fibrillation. Am J Cardiol 1987; 59:177 [DOI] [PubMed] [Google Scholar]
- 11. Gajewski J, Singer RB: Mortality in insured population with atrial fibrillation. J Am Med Assoc 1981; 245:1540–1544 [PubMed] [Google Scholar]
- 12. Kannel WB, Abbott RD, Savage DD, McNamara PM: Epidemiologic features of chronic atrial fibrillation: The Framingham Study. N Engl J Med 1982; 306:1018–1022 [DOI] [PubMed] [Google Scholar]
- 13. Abe Y, Fukunami M, Yamada T, Ohmori M, Shimonagata T, Kumagai K, Kim J, Sanada S, Hori M, Hoki N: Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal‐averaged electrocardiography. Circulation 1997; 96:2612–2616 [DOI] [PubMed] [Google Scholar]
- 14. Petersen P: Thromboembolic complications of atrial fibrillation and their prevention: A review. Am J Cardiol 1990; 65:24C–28C [DOI] [PubMed] [Google Scholar]
- 15. Monorris JJ Jr, Estes H Jr, Whalen RE, Thompson HK Jr, McIntosh HD: P‐wave analysis in valvular heart disease. Circulation 1964; 29:242–252 [DOI] [PubMed] [Google Scholar]
- 16. Feigenbaum H, (ed.): Echocardiography. Philadelphia: Lea & Febiger, 1981. [Google Scholar]
- 17. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839–843 [DOI] [PubMed] [Google Scholar]
- 18. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK: Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135:733–738 [DOI] [PubMed] [Google Scholar]
- 19. Bailey GWH, Branitt BA, Hancock EW, Cohn KE: Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med 1968; 69:13–20 [DOI] [PubMed] [Google Scholar]
- 20. Waggoner AD, Adyanthaya AV, Quinones MA, Alexander JK: Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria. Circulation 1976; 54:553–557 [DOI] [PubMed] [Google Scholar]
- 21. Fukunami M, Yamada T, Ohmori M, Kumagai K, Umemoto K, Sakai A, Kondoh N, Minamino T, Hoki N: Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave‐triggered signal‐averaged electrocardiogram. Circulation 1991; 83:162–169 [DOI] [PubMed] [Google Scholar]
- 22. Stafford PJ, Turner I, Vincent R: Quantitative analysis of signal‐averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol 1991; 68:751–755 [DOI] [PubMed] [Google Scholar]
- 23. Guidera SA, Steinberg JS: The signal‐averaged P wave duration: A rapid and noninvasive marker of risk of atrial fibrillation. J Am Coll Cardiol 1993; 21:1645–1651 [DOI] [PubMed] [Google Scholar]
- 24. Yamada T, Fukunami M, Kumagai K, Abe Y, Kim J, Sanada S, Hori M, Kamada T, Hoki N: Detection of patients with sick sinus syndrome by use of low amplitude potentials early in filtered P wave. J Am Coll Cardiol 1996; 28:738–744 [DOI] [PubMed] [Google Scholar]
- 25. Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, Brady PM, Kay FR: Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 1985; 6:1402–1407 [DOI] [PubMed] [Google Scholar]